Brought to you by 
Qpex spins off from TMC, raises $33mm in Series A round
25 Oct 2018
Executive Summary
Qpex Biopharma Inc. spun off from the The Medicines Co. (TMC) raising $33mm in its Series A financing led by New Enterprise Associates, which was joined by Adams Street Partners, LYZZ Capital, Hatteras Venture Partners, and Stanford University Draper Fund. According to the Form D, ten investors participated.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Spin-Off
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Qpex spins off from TMC, raises $33mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice